Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

2,805 questions · 2,912 findings · 307 reviews · Headline outcomes only

No studies found 706 · 24.2%GRADE not reported 133 · 4.6%Very low 786 · 27%Low 696 · 23.9%Moderate 474 · 16.3%High 117 · 4%

Antihypertensive drug class vs placebo

Calcium channel blocker (any dose) Mean duration of 3 weeks · children (from 1 to 18 years of age) with hypertension from primary or secondary causes
2 findings from 1 review

Antihypertensive drug class vs placebo

Beta‐blocker/thiazide combination (any dose) Mean duration of 10 weeks · children (from 1 to 18 years of age) with hypertension from primary or secondary causes
2 findings from 1 review

Intervention not reported

Angiotensin receptor blocker (high‐ versus low‐dose) · children (from 1 to 18 years of age) with hypertension from primary or secondary causes
1 finding from 1 review

Intervention not reported

Reported complications Laser capsulotomies for posterior capsule opacification (PCO) · Participants over age of 21 years undergoing cataract surgery

The intervention may leads to higher reported complications Laser capsulotomies for posterior capsule… (low certainty).

1 finding from 1 review

Intervention not reported

Primary outcome: improvement in symptoms (respiratory distress/dyspnoea) · 23 patients aged two years or older with recurrent respiratory papillomatosis

The review found no eligible studies for this question.

1 finding from 1 review

Intervention not reported

Primary outcome: improvement in symptoms (voice quality) · 23 patients aged two years or older with recurrent respiratory papillomatosis

The review found no eligible studies for this question.

1 finding from 1 review

Intervention not reported

Primary outcome: improvement in quality of life · 23 patients aged two years or older with recurrent respiratory papillomatosis

The review found no eligible studies for this question.

1 finding from 1 review

Intervention not reported

Primary outcome: recurrence‐free interval · 23 patients aged two years or older with recurrent respiratory papillomatosis

The review found no eligible studies for this question.

1 finding from 1 review

Intervention not reported

Reduction in mortality · 23 patients aged two years or older with recurrent respiratory papillomatosis

The review found no eligible studies for this question.

1 finding from 1 review

Intervention not reported

Reduction in number and/or frequency of surgical interventions and/or time until first relapse requiring surgery · 23 patients aged two years or older with recurrent respiratory papillomatosis

The review found no eligible studies for this question.

1 finding from 1 review

Intervention not reported

Reduction in number and/or duration of hospital stay(s) · 23 patients aged two years or older with recurrent respiratory papillomatosis

The review found no eligible studies for this question.

1 finding from 1 review